Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/20/2003US20030216547 Comprises hexadecapeptide for diagnosis and treatment of nervous system disorders
11/20/2003US20030216546 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
11/20/2003US20030216545 Comprises nucleotide sequences coding g-protein coupled receptors for diagnosing and treating cancer
11/20/2003US20030216544 Methods and reagents for diagnosis of autoantibodies
11/20/2003US20030216543 Insulin purification using simulated moving bed technology
11/20/2003US20030216542 Modified insulin for delivery to lungs by breathing and treatment of diabetes
11/20/2003US20030216541 Systemic administration of a therapeutic preparation
11/20/2003US20030216343 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216342 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216339 Gene sequences associated with neural plasticity and methods related thereto
11/20/2003US20030216332 Nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins; used to treat muscular distrophy
11/20/2003US20030216323 Ku-70-derived Bax-suppressing peptides and use thereof for the protection of damaged cells
11/20/2003US20030216321 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
11/20/2003US20030216318 Inhibition of transmission of tick-borne infections
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216315 Modulation of immune response by non-peptide binding stress response polypeptides
11/20/2003US20030216312 Administering a bactericidal/permeability-increasing (BPI) protein product
11/20/2003US20030216311 Maternally transcribed protein
11/20/2003US20030216310 Expression vectors, host cells, antibodies, agonists, and antagonists.
11/20/2003US20030216309 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
11/20/2003US20030216308 NOVX polynucleotides and polypeptides utilized in the detection and treatment of a broad range of pathological states
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030216304 Novel proteins and nucleic acids encoding same
11/20/2003US20030216299 Stimulating the proliferation or survival of a hematopoietic cell
11/20/2003US20030216296 Amino acid sequences that mediate effective delivery of nucleic acids into cells and tissues, optionally using liposomes
11/20/2003US20030216295 E-selectin-dependent cell adhesion antagonists
11/20/2003US20030216286 Methods and compositions for inhibiting angiogenesis
11/20/2003US20030215950 Isolated polynucleotides and methods of promoting a morphology in a fungus
11/20/2003US20030215948 Comprises adenoviral particle with reduced binding responses to heparin sulfate proteoglycans (HSP) for use as tools in gene therapy and genetic engineering
11/20/2003US20030215922 Comprises genetically engineered metallothionein-streptavidin fusion protein for use as diagnostic tool; preventative in therapeutic medicine
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215916 Comprises nucleotide sequences coding membrane protein for diagnosisng and treating tumor, nervous sytem, reproductive, pain and sexual disorders
11/20/2003US20030215914 Invention provides versatile context for presenting desired affinity regions; provides structural context design based on a common structural element (core structure) that has been identified herein to occur in numerous binding proteins
11/20/2003US20030215913 Comprises nucleotide sequences coding transfroming growth factor (LP266) for treating nervous system, cell proliferative, bone, fibrotic and cardiovascular disorders; wound healing/antiproliferative agents; tissue repair
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215909 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215908 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215905 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215897 Purifying target proteins using post-synaptic density 95, discs-large and zonular occludens (PDZ1) domain and a no receptor potential A (NorpA) sequence soluble matrix
11/20/2003US20030215894 Protein-induced monoclonal receptors to protein ligands
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215888 Genetically engineered myoblast for identifying antiproliferative agents; antiapoptosis; drug screening
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215878 Novel G protein-coupled purinergic receptor, GAVE17
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215873 Methods for identifying and using MarR family polypeptide binding compounds
11/20/2003US20030215861 Methods of treating a BRCA associated disorder
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215846 Methods of constructing and screening diverse expression libraries
11/20/2003US20030215838 Cytokine receptor zcytor17 multimers
11/20/2003US20030215833 Variant cleavage stimulation factor and its encoding nucleic acid
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215824 Identifying modulators of apoptosis such as XIAP associated factor 1 (XAF-1); for treating and diagnosing cell proliferative disorders; drug screening; antiproliferative agents
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215817 Modulation of gene expression in formation of fatty atherosclerotic lesions
11/20/2003US20030215813 Isolated nucleic acid encoding a polypeptide of given amino acid sequence; expression vectors; identification of modulators useful for the treatment of mental/brain disorders
11/20/2003US20030215805 Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancer
11/20/2003US20030215803 Isolated polynucleotide which hybridizes to given sequence; use in diagnosing cancer and for inhibiting tumor growth
11/20/2003US20030215797 Vaccines and immunotherapeutics derived from the human immunodeficiency virus ( HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease
11/20/2003US20030215795 Highly infectious rubella virus DNA constructs and methods of production
11/20/2003US20030215794 Filovirus vectors and noninfectious Filovirus-based particles
11/20/2003US20030215793 Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215788 Of given amino acid sequence; ethylcarbamoyl; useful for detecting antibodies or antigens associated with retroviruses
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215469 Multicomponent meningococcal vaccine
11/20/2003US20030215468 Soluble recombinant botulinum toxin proteins
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215458 Comprise wilms' tumor suppressor gene(wt1) polynucleotide, polypeptide, antigen-presenting cell presenting WT1 polypeptide, antibody that specifically binds to or T cell that specifically reacts with WT1 polypeptide; immunotherapy
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215456 Administering either sequentially in any order or simultaneously amounts of at least two therapeutic agents selected from a compound which is a PSA conjugate and a tachykinin receptor antagonist
11/20/2003US20030215451 In treatment (including prevention) or identification of a human subject at risk of tissue damage, preferably liver or heart tissue damage
11/20/2003US20030215449 Method of treating or delaying onset of angiogenic-associated disorder comprising administering to subject an antibody to the polypeptide of SEC1 in an amount sufficient to treat or prevent said angiogenic associated disorder
11/20/2003US20030215445 Concerns an 88 kDa glycoprotein growth factor ("GP88" or "PCDGF") and compositions and methods which affect the expression and biological activity of GP88; useful for diagnosis and treatment of diseases
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215442 Methods and compositions for the treatment or prevention of immune disorders using combination therapy
11/20/2003US20030215438 Enzyme treatment of foodstuffs for celiac sprue
11/20/2003US20030215437 Polypeptide compositions and methods
11/20/2003US20030215427 CE7-specific redirected immune cells
11/20/2003US20030215425 Epitope synchronization in antigen presenting cells
11/20/2003US20030215422 Aav4 vector and uses thereof
11/20/2003US20030215421 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003US20030215389 Methods for detecting vasculopathies and tumors
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003US20030213047 Necktie wearing device
1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 2916